Skip to main content

Alpha-Blocker Induced Hypotension and Fluid Retention Prevented by Nonselective Beta-Blockers

  • Chapter
  • 98 Accesses

Abstract

In a double-blind placebo controlled crossover trial of 24 weeks 31 patients with Raynaud’s syndrome were treated with the alpha-blocker phenoxybenzamine (10–20 mg daily) and with the combination of the alpha-blocker phenoxybenzamine (10–20 mg daily) and the beta-blocker Sotalol (40–80 mg daily). A favorable effect on recovery of finger temperature after finger cooling was demonstrated after alpha-blockade as compared to the before treatment situation. This favorable effect was not different when the group received the combined alpha- and beta-blockade. The blood pressure was not influenced by either of the 2 medications. Fluid retention appeared with alpha-blockade and was absent with combined alpha- and beta-blockade. Decrease of heart rate occurred with alpha-plus beta-blockade and was absent with alpha-blockade alone. Clinical symptoms of Raynaud’s syndrome were equally alleviated by the two medications. Common, and equally frequent side effects of the two medications were nasal congestion, disturbed ejaculation and potence, dry mouth, exercise-induced, and orthostatic dizziness.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cleophas AJM, Fennis JFM, van’t Laar A: Alpha-and beta-blockade and beta-stimulation in Raynaud’s syndrome. A double blind controlled trial. Neth J Med 25: 56 (abstract), 1982.

    Google Scholar 

  2. Friend DG, Edwards EA: Use of “Dibenzyline” as a vasodilator in patients with severe digital ischemia. Arch Int Med 93: 928–937, 1954.

    Article  CAS  Google Scholar 

  3. Trübestein G, Sobbe A: Morbus Raynaud-Raynaud-syndrome. Med Klin 48: 1990–1995, 1974.

    Google Scholar 

  4. Porter JM, Snider RL, Bardana EM, Rösch J, Eidemiller LR: The diagnosis and treatment of Raynaud’s phenomenon. Surgery 77: 11–23, 1975.

    PubMed  CAS  Google Scholar 

  5. Waldo R: Prazosin relieves Raynaud’s vasospasm. JAMA 241: 1037, 1979.

    Article  PubMed  CAS  Google Scholar 

  6. Brecht Th, Hengstmann JH: Therapeutic effects of intra-arterial phentolamine in “Raynaud’s syndrome”. Klin Wsch 59: 397–401, 1981.

    Article  CAS  Google Scholar 

  7. Hoffman BB, Lefkowitz RJ: Alpha-adrenergic receptor subtypes. N Engl J Med 302: 1390–1396, 1980.

    Article  PubMed  CAS  Google Scholar 

  8. Coffman JD: Raynaud’s phenomenon and disease, in Cecil Textbook of Medicine, edited by Beeson & McDermott, pp 1305–1307, 1979.

    Google Scholar 

  9. Cleophas AJM, Fennis JFM, van ‘t Laar A: Treatment of vasospastic disease with prostaglandin E1. Br Med J 282: 1476, 1981.

    Article  CAS  Google Scholar 

  10. Cleophas AJM, Fennis JFM, van ‘t Laar A: Finger temperature after a finger cooling test. Influence of air temperature and cigarette smoking. J Appl Physiol 52: 1167–1171, 1982.

    PubMed  CAS  Google Scholar 

  11. Hills M, Armitage P: The two-period crossover trial. Br J Clin Pharmacol 8: 7–20, 1979.

    Article  PubMed  CAS  Google Scholar 

  12. Brown BW: The crossover experiment for clinical trials. Biometrics 36: 69–79, 1980.

    Article  PubMed  Google Scholar 

  13. Simpson FO: Hypertensive disease. In Drug Treatment, edited by Graene S. Avery, pp 655–682, 1980.

    Google Scholar 

  14. Barker N, Hews RJ, Huitson A, Poloniecki J: The two period crossover trial. Bias 9: 67–117, 1982.

    Google Scholar 

  15. Koch-Weser J: Vasodilator drugs in the treatment of hypertension. Arch Int Med 144: 1017–1027, 1974.

    Article  Google Scholar 

  16. Attila M, Arstila M, Pfeffer M, Tikkanen R, Vallinkoski V, Sundquist H: Human pharmacokinetics of Sotalol. Acta Pharmacol Toxicol 39: 118–128, 1976.

    Article  Google Scholar 

  17. Zacharias FJ: Patient acceptibility of propranolol and the occurrence of side effects. Postgrad Med J (Suppl) 52: 87–89, 1976.

    PubMed  Google Scholar 

  18. Marshall, AJ, Roberts CJC, Barritt DW: Raynaud’s phenomenon as side effect of beta-blockers in hypertension. Br Med J 1: 1498–1499, 1976.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Cleophas, T.J.M. (1995). Alpha-Blocker Induced Hypotension and Fluid Retention Prevented by Nonselective Beta-Blockers. In: Beta-Blockers in Hypertension and Angina Pectoris. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0129-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-0129-5_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-3516-0

  • Online ISBN: 978-94-011-0129-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics